586 / 1241
A.
B.
C.
D.
E.
6% 6%
9%
77%
3%
Question 3: Pseudoprogression
A. Occurs in Glioblastoma after
concomittant RT-TMZ in 5%
of patients
B. It occurs at 5 months after RT
C. Is more frequent in patients
sensitive to TMZ
D. Molecular and functional
imaging can help differenciate
true progression from
pseudoprogression
E. It has on impact on response
to clinical trials